This week’s report in New England Journal of Medicine of two unusual Utah Zika cases raises questions about Zika virus transmission and virulence. Read about it in this NPR news feature.
IDbyDNA announces today that it has closed $9 million in Series A financing to develop its Taxonomer-based infectious disease diagnostic technologies.
In this Scope Radio Interview, Dr. Lynn Jorde and Dr. Eric Green discuss opportunities and challenges in Genomic Medicine.
Aaron Quinlan discusses his software tool GEMINI and uncovering the the genetic cause of seizures in nearly a dozen infants.
Drs. Robert Schlaberg and Mark Yandell talk about the future of medicine and metagenomics in this KSL.com news feature.
Drs. Martin Tristani-Firouzi and Mark Yandell launch the Sudden Death in the Young project to discover the genetic causes of sudden cardiac death.
Scientists from the USTAR Center for Genetic Discovery spend the day at the Natural History Museum discussing genomics and genetic traits.
Dr. Gabor Marth talks about how a visual, interactive, and accessible web interface can put the power of a supercomputer into the hands of average people.
Dr. Robert Schlaberg was awarded a Global Grand Challenges award from the Bill and Melinda Gates Foundation to study fatal childhood infectious diseases in resource-limited settings.
Investigators from the USTAR Center for Genetic Discovery, ARUP Laboratories, and IDbyDNA have teamed up to produce Taxonomer, an ultrafast metagenomic analysis tool published today in Genome…
The USTAR Center for Genetic Discovery has used the FastQForward pipeline to analyze over a thousand human genome sequences in collaboration with projects like the Utah Genome Project and the Utah Pediatric Cardiac Genomics Consortium.
This month, two publications appear in a special issue of the journal Nature celebrating 25 years since the launch of the Human Genome Project and marking the completion of The 1000 Genomes Project, launched in 2008.
A new collaboration with Regeneron Genetics Center combines the power of Utah’s computational genomics with Regeneron’s strength in pharmacogenomics to identify novel targets for drug development.
